Key points are not available for this paper at this time.
This thorough QTc study suggests that a supra-therapeutic single 400 mg oral dose of tafamidis does not prolong the QTc interval and is well-tolerated in healthy volunteers.
Building similarity graph...
Analyzing shared references across papers
Loading...
Klamerus et al. (Wed,) studied this question.
www.synapsesocial.com/papers/69dbc38f387cf70698688a50 — DOI: https://doi.org/10.1111/bcp.12561
Karen J. Klamerus
Eric Watsky
Robert A. Moller
British Journal of Clinical Pharmacology
Pfizer (United States)
Building similarity graph...
Analyzing shared references across papers
Loading...